Get an overview of this COA-focused panel at the C3 Summit in London where industry experts and leaders discussed challenges, opportunities, and strategies in clinical trial diversity, centricity, and outcome assessments.

See how digital solutions came together to enable faster study startup by 50% for this top pharma company conducting a Phase 3 diabetes study within the weight loss market.

Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.

Sites are frequently overwhelmed with the sheer number of technologies they must work with to conduct a clinical trial, and this aggregation platform can streamline trial management.

Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.

<p>While the digital transformation of clinical trials has made tremendous strides in recent years, the plethora of new technologies can overwhelm. Learn how to help sites and sponsors combat the overload of technology.</p>

As trials continue to digitize, learn how connected sensors, COAs, PROs, and other forms of data will come together to form the evidence of tomorrow.

eCOA solutions enhance data quality in clinical trials by preventing common issues in paper-based COA data, such as missing, ambiguous, or conflicting entries, and ensuring reliable data collection.

FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.